Melanoma Research Victoria

Anna C. Pavlick, DO, professor in the Department of Medicine and Ronald O. Perelman Department of Dermatology, as well as the director of High Reliability Organization Initiatives and the co-director of the Melanoma Program at NYU Langone Health’s Perlmutter Cancer Center, discusses updated results from the COLUMBUS trial in metastatic melanoma.

Read the full story

Jeffrey S. Weber, MD, PhD, deputy director and co-director of the melanoma program, Laura and Isaac Perlmutter Professor of Oncology, Department of Medicine, NYU Langone’s Perlmutter Cancer Center, 2016 Giant of Cancer Care® in Melanoma, discusses emerging immunotherapy combinations in melanoma.

Read the full story

Jason J. Luke, MD, FACP, associate professor of medicine, Division of Hematology/Oncology, and director of the Cancer Immunotherapeutics Center within the Immunology and Immunotherapy Program, University of Pittsburgh Medical Center Hillman Cancer Center, discusses predictive biomarkers in metastatic melanoma.

Read the full story

Richard L. Shapiro, MD, associate professor, Department of Surgery, NYU Langone Health’s Perlmutter Cancer Center, discusses the surgical management of advanced-stage melanoma.

Read the full story